Androgenic alopecia. Androgenic alopecia, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Women aged 18 to 60 years old Type 1 to 2 hair loss according to the Hamilton Hair Loss Criterion that has lasted more than 6 months Patient consent approval to participate in the study
Exclusion criteria
Exclusion criteria: Records of using any typical products to prevent hair loss or stimulate hair growth in the past 2 months Utilizing 5 a reductase inhibitors in the past 2 months Records of taking anti-androgenic drugs in the past 2 months Records of systemically taken steroids for more than 14 days in the past 2 months Any active diseases in the head including scalp infection in the past 6 months Records of any types of cancer or autoimmune diseases Any records of hair transplantation Pregnancy and lactation The history of underlying diseases of diabetes, hypothyroidism, polycystic ovary syndrome The history of acute illness in the last 2 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of hair strands. Timepoint: Before intervention, 12 weeks after the intervention. Method of measurement: Trichoscan.;Terminal hair to Volos hair. Timepoint: Before intervention, 12 weeks after the intervention. Method of measurement: Trichoscan.;Ratio of anagen to telogen hair. Timepoint: Before intervention, 12 weeks after the intervention. Method of measurement: Trichoscan.;Physician satisfaction with treatment. Timepoint: Before intervention, 6 and 12 weeks after the intervention. Method of measurement: questionnaire.;Patient satisfaction with treatment. Timepoint: Before intervention, 6 and 12 weeks after the intervention. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences